Fairvalue-Calculator Fairvalue-Calculator
EN DE

Carilex Medical, Inc (7726) Fair Value & Analysis

Healthcare · TW · Market cap 658M TWD

Price32.40 TWD
Fair Value42.99 TWD
Upside+32.7%
Quality95/100
Evidence: Medium Range 32.24 TWD – 53.73 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Carilex Medical, Inc (7726) currently trades at 32.40 TWD, while our model-based Fair Value estimate is 42.99 TWD — implying the stock looks roughly 32.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Carilex Medical, Inc (7726) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 42.99 TWD versus a price of 32.40 TWD — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 7726?
Our 21-model fair value for Carilex Medical, Inc is 42.99 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 32.40 TWD.
What is the quality score of 7726?
Carilex Medical, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.